ARDT - Company ID 0001756655
The table below shows Ardent Health, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $1.60B | $1.58B | $1.65B | $1.50B | $1.45B | $1.47B |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A |
Ardent Health, Inc. reported annual revenue of $6.32B for fiscal year 2025. That is up 6.0% from $5.97B in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $48.60M |
| $36.50M |
| $32.60M |
| $34.90M |
| $33.70M |
| $29.10M |
| Operating income | - | - | - | - | - | - |
| Income tax | $16.10M | -$3.41M | $26.29M | $15.23M | $11.06M | $15.22M |
| Net income | $39.85M | -$23.48M | $72.95M | $41.38M | $26.32M | $42.77M |
| EPS (diluted) | $0.28 | -$0.17 | $0.52 | $0.29 | $0.19 | $0.34 |